Our Interventional Cardiology Center is exceptional. As such, Boston Scientific sought out our Heart Center cardiologists to perform the innovative WATCHMAN™ closure device procedure, making us the third hospital in Florida to offer this life-saving implant. Our interventional cardiologists focus on complex coronary disease, structural heart disease and peripheral vascular disease and are leaders in interventional cardiovascular medicine.
Transfemoral Aortic Valve Replacement (TAVR)
Lakeland Regional Health Medical Center’s Heart Center has been among the first in Florida to offer patients percutaneous transfemoral aortic valve replacement for patients with aortic stenosis. Also known as “TAVR,” this procedure is specifically for patients who are at high surgical risk due to their advanced age or fragile condition.
This minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve’s place. The aortic valves can be placed via the femoral artery or, if the femoral artery is too small, surgeons can use an apical approach. These types of approaches eliminate the need for open heart surgery for aortic valve replacement.
Andres Medina, MD, helped pioneer the TAVR procedure. Beginning in 2008, he served as one of two surgical investigators participating in the PARTNER trial for the state, which was published in the New England Journal of Medicine and led to FDA approval for TAVR. Dr. Medina performed the first TAVR procedure in Florida and has since evaluated hundreds of successfully completed TAVR cases and proctored other surgeons as they learned to master its techniques.
During the TAVR procedure, an FDA-approved bioprosthetic valve, which is manufactured by Edwards Lifesciences, is inserted through a catheter and implanted within the diseased aortic valve.
WATCHMAN™ (left atrial appendage closure)
Lakeland Regional Health Medical Center is was chosen as the third hospital in Florida to perform this procedure. The WATCHMAN™ device is intended for patients with nonvalvular atrial fibrillation and who are at high risk of stroke while on warfarin, a blood thinner. A physician inserts this closure device through the femoral vein up to the left atrial appendage, where it sits and totally closes the appendage. By closing off the appendage, the risk of stroke may be reduced and, over time, patients may be able to stop taking the drug warfarin.
Hybrid Catheterization Lab
Lakeland Regional Health Medical Center offers Polk County’s only Hybrid Catheterization Lab. This revolutionary one-stop concept allows patients to undergo cutting-edge procedures for aneurysm repair, valve replacements and shunt closure devices in a room integrated with the latest imaging devices. The hybrid catheterization lab enables both surgical and intravascular procedures to occur sequentially or simultaneously, without moving the patient from one procedure room to another.
Our Hybrid Catheterization Lab, which opened in 2012, allows cardiologists and surgeons to perform transfemoral aortic valve replacements for patients at high risk for open-heart procedures. This less invasive procedure allows for highly reduced hospital stays, less scarring and quicker recoveries for patients.
Our Interventional Cardiology Center also provides:
- Balloon Angioplasties and Stenting
- Coronary Atherectomy
- Coronary Physiology and Microcirculation Assessment
- Coronary Stents
- Diagnostic Catheterization
- Endomyocardial Biopsy
- Evaluation of Complex Valvular Disease
- Hemodynamic Assessment
- Intracardiac and Intravascular Ultrasound
- Peripheral Vascular Disease treatments, such as carotid artery stenting, renal artery stenting and peripheral artery stenting